Kennedy Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-104,881
| Closed | -$2.35M | – | 622 |
|
|
2022
Q3 | $2.35M | Sell |
104,881
-725
| -0.7% | -$16.2K | 0.07% | 391 |
|
|
2022
Q2 | $2.62M | Sell |
105,606
-1,194
| -1% | -$29.6K | 0.07% | 386 |
|
|
2022
Q1 | $4.14M | Buy |
106,800
+848
| +0.8% | +$32.9K | 0.1% | 347 |
|
|
2021
Q4 | $6.2M | Sell |
105,952
-21,158
| -17% | -$1.24M | 0.13% | 295 |
|
|
2021
Q3 | $7.53M | Buy |
127,110
+16,584
| +15% | +$983K | 0.17% | 224 |
|
|
2021
Q2 | $9.59M | Buy |
+110,526
| New | +$9.59M | 0.21% | 172 |
|
|
2020
Q2 | – | Sell |
-75,200
| Closed | -$1.67M | – | 679 |
|
|
2020
Q1 | $1.67M | Buy |
+75,200
| New | +$1.67M | 0.06% | 493 |
|